185 related articles for article (PubMed ID: 34182874)
1. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
Dong Y; Lu Y; Xia Y; Wang X
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
[TBL] [Abstract][Full Text] [Related]
2. Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesis.
D'Ippolito S; Marana R; Di Nicuolo F; Castellani R; Veglia M; Stinson J; Scambia G; Di Simone N
PLoS One; 2012; 7(1):e29660. PubMed ID: 22235321
[TBL] [Abstract][Full Text] [Related]
3. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
[TBL] [Abstract][Full Text] [Related]
4. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function.
Albert CR; Schlesinger WJ; Viall CA; Mulla MJ; Brosens JJ; Chamley LW; Abrahams VM
Am J Reprod Immunol; 2014 Feb; 71(2):154-64. PubMed ID: 24325143
[TBL] [Abstract][Full Text] [Related]
5. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
[TBL] [Abstract][Full Text] [Related]
6. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies.
Marchetti T; Ruffatti A; Wuillemin C; de Moerloose P; Cohen M
J Thromb Haemost; 2014 Jun; 12(6):910-20. PubMed ID: 24656088
[TBL] [Abstract][Full Text] [Related]
8. The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies.
Schreiber K; Breen K; Parmar K; Rand JH; Wu XX; Hunt BJ
Rheumatology (Oxford); 2018 Jan; 57(1):120-124. PubMed ID: 29045759
[TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies affect human endometrial angiogenesis.
Di Simone N; Di Nicuolo F; D'Ippolito S; Castellani R; Tersigni C; Caruso A; Meroni P; Marana R
Biol Reprod; 2010 Aug; 83(2):212-9. PubMed ID: 20393166
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy and Antiphospholipid Syndrome.
Schreiber K; Hunt BJ
Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
Rand JH; Wu XX; Quinn AS; Chen PP; Hathcock JJ; Taatjes DJ
Blood; 2008 Sep; 112(5):1687-95. PubMed ID: 18577708
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases.
Khizroeva J; Bitsadze V; Tincani A; Makatsariya A; Arslanbekova M; Babaeva N; Tsibizova V; Shkoda A; Makatsariya N; Tretyakova M; Solopova A; Gadaeva Z; Vorobev A; Khamani I; Aslanova Z; Nakaidze I; Mischenko A; Grigoreva K; Kunesko N; Egorova E; Mashkova T
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6157-6164. PubMed ID: 34044735
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
Arachchillage DJ; Laffan M; Pericleous C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
[TBL] [Abstract][Full Text] [Related]
16. The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome.
Fierro JJ; Velásquez-Berrío M; Ospina A; Henning S; de Leeuw K; Cadavid J ÁP
Rheumatol Int; 2024 Feb; 44(2):223-234. PubMed ID: 37741812
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of β(2) glycoprotein I.
Di Simone N; D'Ippolito S; Marana R; Di Nicuolo F; Castellani R; Pierangeli SS; Chen P; Tersigni C; Scambia G; Meroni PL
Am J Reprod Immunol; 2013 Oct; 70(4):299-308. PubMed ID: 23650919
[TBL] [Abstract][Full Text] [Related]
18. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review.
Hooper A; Bacal V; Bedaiwy MA
Am J Reprod Immunol; 2023 Sep; 90(3):e13761. PubMed ID: 37641373
[TBL] [Abstract][Full Text] [Related]
19. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni PL
J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
Belizna C
Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]